Satellos Bioscience MSLE
NASDAQ MSLE
$6.63 -0.07 (-1.12%)
As of: Oct 22, 2026 · 3:53 PM EDT

Satellos Bioscience (MSLE) Share-based Compensation (2025 - 2026)

Updated

Satellos Bioscience's Share-based Compensation came in at $922,000 for the quarter ended Jun 30, 2026, up 10.6% from $834,000 a year earlier and up 26.8% from the prior quarter.

Analysis

Satellos Bioscience (MSLE) Share-based Compensation (2025 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Satellos Bioscience reported Share-based Compensation of $3.13 million; for the year ended Dec 31, 2025, it was $3.24 million, up 97.1% from the prior year.

  • Going back by year, Share-based Compensation was $1.64 million in the year ended Dec 31, 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 201.00 Mn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 357.00 Mn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 166.00 Mn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 298.00 Mn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn -
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn -
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 165.00 Mn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 231.00 Mn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 249.00 Mn
10 Satellos Bioscience 96.70 Mn -111.44 Mn - 922,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 922,000.00
Mar 31, 2026 727,000.00
Jun 30, 2025 834,000.00
Mar 31, 2025 642,000.00
API Access

Satellos Bioscience Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=MSLE&period=max&api_key=YOUR_API_KEY